Evonik Industries, a German speciality chemicals company, on Monday said it currently expects adjusted earnings before interest, taxes, depreciation, and amortization, or adjusted EBITDA, for the second quarter to be €578 million ($630 million). That was above market expectations of €531 million. “In addition to continued strict cost discipline, good volume development in Speciality Additives, as well as a price recovery in Animal Nutrition and lower production costs were drivers of the sequential increase,” the Essen-based company said in a statement. Subsequently, Evonik has raised its full-…